Selpercatinib

From WikiMD.org
Jump to navigation Jump to search
Selpercatinib
TermSelpercatinib
Short definitionSelpercatinib - (pronounced) (SEL-per-KA-tih-nib) drug used to treat certain types of non-small cell lung cancer or other solid tumors in adults and certain types of thyroid cancer in adults and children 12 years and older that are caused by an abnormal RET gene. It is also being studied in the treatment of other types of cancer. 
TypeCancer terms
SpecialtyOncology
LanguageEnglish
SourceNCI
Comments


Selpercatinib - (pronounced) (SEL-per-KA-tih-nib) drug used to treat certain types of non-small cell lung cancer or other solid tumors in adults and certain types of thyroid cancer in adults and children 12 years and older that are caused by an abnormal RET gene. It is also being studied in the treatment of other types of cancer. Selpercatinib blocks certain proteins, including those made by the RET fusion gene or the mutated RET gene. Blocking these proteins can help prevent cancer cells from growing. Selpercatinib is a type of tyrosine kinase inhibitor. Also called Retevmo

External links

Esculaap.svg

This WikiMD dictionary article is a stub. You can help make it a full article.


Languages: - East Asian 中文, 日本, 한국어, South Asian हिन्दी, Urdu, বাংলা, తెలుగు, தமிழ், ಕನ್ನಡ,
Southeast Asian Indonesian, Vietnamese, Thai, မြန်မာဘာသာ, European español, Deutsch, français, русский, português do Brasil, Italian, polski